All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
APELLIS PHARMACEUTICALS, INC.: Last Reported 5/31/2020

Business Address

100 FIFTH AVENUE

WALTHAM, MA US 02451

Mailing Address

100 FIFTH AVENUE

WALTHAM, MA US 02451
Phone Number: 617-977-5700 / State Incorporated: DE / Fiscal Year End 12/31

Balance Sheet

Date 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015 12/31/2014
Cash and Cash Equivalents $417,900,000.00 $351,985,000.00 $433,994,644.00 $289,100,000.00 $288,246,706.00 $176,267,666.00 $220,640,818.00 $253,839,540.00 $152,930,977.00 $175,643,529.00 $13,135,848.00 $4,939,087.00 $16,436,538.00 $24,863,488.00 $31,408,090.00 -- -- $36,003,546.00 $13,622,995.00
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Assets $672,407,000.00 $373,094,684.00 $451,194,872.00 $308,412,717.00 $310,527,863.00 $202,439,221.00 $238,932,792.00 $266,701,518.00 $163,086,857.00 $182,015,306.00 $19,032,933.00 -- -- $27,368,730.00 -- -- -- -- --
Property Plant and Equipement $1,972,000.00 $1,655,000.00 $1,592,787.00 $1,439,108.00 $1,041,063.00 $977,918.00 -- -- -- -- -- -- -- -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $845,000.00 $385,088.00 $236,515.00 $207,873.00 $162,345.00 $116,420.00 $212,979.00 $116,150.00 $116,150.00 $116,150.00 $108,350.00 -- -- $64,528.00 -- -- -- -- --
Total Assets $688,939,000.00 $389,244,980.00 $466,356,957.00 $316,704,010.00 $318,353,078.00 $203,533,559.00 $239,145,771.00 $266,817,668.00 $163,203,007.00 $182,131,456.00 $19,141,283.00 -- -- $27,433,258.00 -- -- -- -- --
Accounts Payable $3,078,000.00 $8,360,527.00 $11,836,609.00 $13,811,730.00 $11,916,152.00 $10,254,938.00 $5,468,800.00 $5,133,017.00 $4,585,058.00 $3,663,253.00 $4,001,059.00 -- -- $2,547,212.00 -- -- -- -- --
Accrued Liabilities $44,930,000.00 $54,783,000.00 $30,431,607.00 $20,229,694.00 $7,342,601.00 $5,103,002.00 $10,565,640.00 $5,121,178.00 $2,709,801.00 $2,890,705.00 $2,936,885.00 -- -- $1,091,726.00 -- -- -- -- --
Total Current Liabilities $429,942,000.00 $355,016,000.00 $326,795,143.00 $157,617,972.00 $93,598,186.00 $42,560,904.00 $43,190,921.00 $37,265,562.00 $34,160,902.00 $33,188,596.00 -- -- -- $3,638,938.00 -- -- -- -- --
Long Term Debt -- -- -- -- -- -- $27,000,000.00 $27,000,000.00 $27,000,000.00 $27,000,000.00 -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $1,010,000.00 $-153,775.00 $-205,249.00 $-121,977.00 $-120,645.00 $-122,807.00 $339,942.00 -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-750,295,000.00 $-581,472,460.00 $-468,255,037.00 $-398,430,378.00 $-327,340,214.00 $-276,765,847.00 $-240,306,373.00 $-204,334,259.00 $-170,999,957.00 $-149,263,653.00 $-131,007,757.00 -- -- $-98,257,559.00 -- -- -- -- --
Total Stockholders' Equity $258,997,000.00 $34,229,676.00 $139,561,814.00 $159,086,038.00 $224,754,892.00 $160,972,655.00 $195,954,850.00 $229,552,106.00 $129,042,105.00 $148,942,860.00 $12,203,339.00 -- -- $23,794,320.00 -- -- -- $34,976,949.00 $13,224,707.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $688,939,000.00 $389,245,000.00 $466,356,957.00 $316,704,010.00 $318,353,078.00 $203,533,559.00 $239,145,771.00 $266,817,668.00 $163,203,007.00 $182,131,456.00 $19,141,283.00 -- -- $27,433,258.00 -- -- -- -- --

Statement of Operations

Date 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015 12/31/2014
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $69,282,000.00 $220,968,770.00 $142,497,342.00 $91,178,326.00 $40,479,899.00 $105,285,576.00 $74,479,965.00 $27,537,619.00 $17,402,890.00 $40,303,878.00 $27,171,025.00 $17,653,143.00 $7,231,084.00 $22,978,599.00 $6,234,058.00 -- -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Loss from Operations $-98,786,000.00 $-105,940,283.00 $-182,074,969.00 $-112,127,008.00 $-48,650,570.00 $-127,924,760.00 $-35,804,581.00 $-54,923,588.00 $-21,438,145.00 $-17,568,845.00 $-11,589,319.00 $-21,184,896.00 $-9,214,375.00 $-27,282,342.00 $-7,234,204.00 $-7,572,638.00 $-6,228,452.00 $-46,573,093.00 --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 87,000,000 -- -- 87,000,000 -- -- -- -- --
Common Stock Shares Outstanding 75,400,000 63,900,000 63,872,762 63,672,430 63,218,476 56,279,307 56,242,571 56,154,438 50,429,020 50,334,152 8,472,903 -- -- 8,428,366 -- -- -- -- --
Copyright 2020 PursePoor.com